Tandem Diabetes (TNDM) Care Announces FDA Clearance of Control-IQ+ Automated Insulin Delivery Technology for People with Type 2 Diabetes

Go back to Tandem Diabetes (TNDM) Care Announces FDA Clearance of Control-IQ+ Automated Insulin Delivery Technology for People with Type 2 Diabetes
TANDEM DIABETES (NASDAQ: TNDM) Delayed: 14.34 -0.96 (6.27%)
Previous Close $15.30    52 Week High $12.48 
Open $15.17    52 Week Low $1.60 
Day High $15.34    P/E N/A 
Day Low $14.32    EPS $-6.33 
Volume 2,451,800